Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lukáš Knybel"'
Autor:
Tomáš Blažek, Marek Petráš, Pavel Hurník, Petr Matoušek, Lukáš Knybel, Zuzana Zděblová Čermáková, Jan Štembírek, Jakub Cvek, Renata Soumarová
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionIn the era of personalized medicine and treatment optimization, use of immune biomarkers holds promise for estimating the prognosis of patients with head and neck squamous cell carcinoma (HNSCC) undergoing definitive treatment.MethodsTo e
Externí odkaz:
https://doaj.org/article/f532011d5f7f4bf0866b6d48cc9402f5
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 41, Iss , Pp 100609- (2023)
Externí odkaz:
https://doaj.org/article/7f79ec0043134394ab04289836c67c5c
Autor:
Tomáš Blažek, Zuzana Zděblová Čermáková, Lukáš Knybel, Pavel Hurník, Jan Štembírek, Kamila Resová, Tereza Paračková, Martin Formánek, Jakub Cvek, Renata Soumarová
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Purpose We evaluated the efficiency and toxicity of stereotactic hypofractionated boost in combination with conventionally fractionated radiotherapy in the treatment of advanced floor of the mouth cancer. Methods Thirty-seven patients with a
Externí odkaz:
https://doaj.org/article/238e011452f1467c8d566c305e7f7ee4
Autor:
Jana Haskova, Petr Peichl, Marek Šramko, Jakub Cvek, Lukáš Knybel, Otakar Jiravský, Radek Neuwirth, Josef Kautzner
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Stereotactic body radiotherapy (SBRT) has been reported as an attractive option for cases of failed catheter ablation of ventricular tachycardia (VT) in structural heart disease. However, even this strategy can fail for various reasons. For the first
Externí odkaz:
https://doaj.org/article/f9fc9f9103204d6290f438a3583fd36d
Autor:
Zuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, Jan Štembírek, Tereza Paračková, Kamila Resová, Jakub Cvek, Tomáš Blažek, Lukáš Knybel, Martin Formánek, Mariam Gachechiladze, Markus Joerger, Alex Soltermann, Jozef Škarda, Oldřich Motyka, Jana Janoutová
Publikováno v:
Medicina, Vol 59, Iss 2, p 361 (2023)
Introduction: The incidence of advanced oral cavity and oropharyngeal cancers is generally high. Treatment outcomes for patients, especially those unfit for comprehensive cancer treatment, are unsatisfactory. Therefore, the search for factors to pred
Externí odkaz:
https://doaj.org/article/dc3fbdc18cc242049c3c14b69da5670d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kautzner, Josef, Jedlickova, Kristina, Sramko, Marek, Peichl, Petr, Cvek, Jakub, Ing, Lukas Knybel, Neuwirth, Radek, Jiravsky, Otakar, Voska, Ludek, Kucera, Tomas
Publikováno v:
In JACC: Clinical Electrophysiology December 2021 7(12):1487-1492
Autor:
Tomáš Kučera, Kristína Jedličková, Marek Šramko, Petr Peichl, Jakub Cvek, Lukáš Knybel, Pavel Hurník, Radek Neuwirth, Otakar Jiravský, Luděk Voska, Josef Kautzner
Publikováno v:
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 62
We performed a histological and immunohistochemical analysis of myocardia from 3 patients who underwent radiosurgery and died for various reasons 3 months to 9 months after radiotherapy. In Case 1 (death 3 months after radiotherapy) we observed a sha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7dd6bb75dd8eae98888315b72a186e
https://pubmed.ncbi.nlm.nih.gov/36206914
https://pubmed.ncbi.nlm.nih.gov/36206914
Publikováno v:
JAMA Network Open. 6:e236324
ImportanceThe failure or success of radical treatment in patients with head and neck squamous cell carcinoma (HNSCC) is associated with many known and unknown factors; hence, there is a search for further prognostic markers to help optimize therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa23ff1f6cb70cdcf5f95622d7404818
https://doi.org/10.1001/jamanetworkopen.2023.6324
https://doi.org/10.1001/jamanetworkopen.2023.6324
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC), but which patients benefit from stereotactic radiotherapy is unclear. The aim of this
Externí odkaz:
https://doaj.org/article/7a87c4fefef646f3af951c286e79ea03